Literature DB >> 22270185

The impact of ferritin fluctuations on stable hemoglobin levels in hemodialysis patients.

Mana Yahiro1, Takahiro Kuragano, Aritoshi Kida, Rie Kitamura, Minoru Furuta, Yukiko Hasuike, Yoshinaga Otaki, Hiroshi Nonoguchi, Takeshi Nakanishi.   

Abstract

BACKGROUND: Hemoglobin (Hb) cycling in patients with renal anemia might be associated with a higher mortality rate. We investigated the association of factors relating serum ferritin and dose of erythropoiesis-stimulating agents (ESAs) with Hb levels.
METHODS: We measured Hb and ferritin levels every month in 266 hemodialysis (HD) patients for 12 months.
RESULTS: The standard deviation (SD) and residual SD (RSD) (liner regression of Hb or ferritin SD values) values of Hb were significantly correlated with ferritin SD or RSD values, respectively. The percentage achievement of target Hb in the target-ferritin group was significantly higher than in the high-amplitude fluctuation ferritin group. Ferritin SD and RSD values in patients with oral or no iron supplementation were significantly lower than those who received intravenous iron.
CONCLUSION: Iron storage varies over a relatively wide range in HD patients, and this variation is closely associated with Hb cycling. The stability of iron storage and ESA dosage is important for maintaining stable Hb levels.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22270185     DOI: 10.1007/s10157-011-0584-0

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  21 in total

Review 1.  Iron overload and cardiovascular complications in dialysis patients.

Authors:  Josef Kletzmayr; Walter H Hörl
Journal:  Nephrol Dial Transplant       Date:  2002       Impact factor: 5.992

2.  Determinants of hepcidin in patients on maintenance hemodialysis: role of inflammation.

Authors:  Takahiro Kuragano; Yasushi Shimonaka; Aritoshi Kida; Minoru Furuta; Masayoshi Nanami; Yoshinaga Otaki; Yukiko Hasuike; Hiroshi Nonoguchi; Takeshi Nakanishi
Journal:  Am J Nephrol       Date:  2010-05-14       Impact factor: 3.754

3.  Relationship between apparent (single-pool) and true (double-pool) urea distribution volume.

Authors:  J T Daugirdas; T Greene; T A Depner; F A Gotch; R A Star
Journal:  Kidney Int       Date:  1999-11       Impact factor: 10.612

4.  Enhanced oxidative stress in haemodialysis patients receiving intravenous iron therapy.

Authors:  P S Lim; Y H Wei; Y L Yu; B Kho
Journal:  Nephrol Dial Transplant       Date:  1999-11       Impact factor: 5.992

5.  Correction of anemia with epoetin alfa in chronic kidney disease.

Authors:  Ajay K Singh; Lynda Szczech; Kezhen L Tang; Huiman Barnhart; Shelly Sapp; Marsha Wolfson; Donal Reddan
Journal:  N Engl J Med       Date:  2006-11-16       Impact factor: 91.245

6.  Ferumoxytol as an intravenous iron replacement therapy in hemodialysis patients.

Authors:  Robert Provenzano; Brigitte Schiller; Madhumathi Rao; Daniel Coyne; Louis Brenner; Brian J G Pereira
Journal:  Clin J Am Soc Nephrol       Date:  2009-01-28       Impact factor: 8.237

7.  Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin.

Authors:  Steven Fishbane; Jeffrey S Berns
Journal:  Kidney Int       Date:  2005-09       Impact factor: 10.612

8.  Hemoglobin level variability: associations with comorbidity, intercurrent events, and hospitalizations.

Authors:  James P Ebben; David T Gilbertson; Robert N Foley; Allan J Collins
Journal:  Clin J Am Soc Nephrol       Date:  2006-09-06       Impact factor: 8.237

9.  Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease.

Authors:  Tilman Drüeke; Véronique Witko-Sarsat; Ziad Massy; Béatrice Descamps-Latscha; Alain P Guerin; Sylvain J Marchais; Valérie Gausson; Gérard M London
Journal:  Circulation       Date:  2002-10-22       Impact factor: 29.690

10.  Inflammation and its impact on anaemia in chronic kidney disease: from haemoglobin variability to hyporesponsiveness.

Authors:  Angel L M de Francisco; Peter Stenvinkel; Sophie Vaulont
Journal:  NDT Plus       Date:  2009-01
View more
  3 in total

1.  The Authors Reply.

Authors:  Takahiro Kuragano; Osamu Matsumura; Akihiko Matsuda; Taiga Hara; Hideyasu Kiyomoto; Toshiaki Murata; Kenichiro Kitamura; Shouichi Fujimoto; Hiroki Hase; Nobuhiko Joki; Atushi Fukatsu; Toru Inoue; Yukihiro Itakura; Takeshi Nakanishi
Journal:  Kidney Int       Date:  2015-07       Impact factor: 10.612

2.  Effect of frequency of intravenous iron administration on hemoglobin variability in maintenance hemodialysis patients.

Authors:  Li Wan; Dongliang Zhang
Journal:  Int Urol Nephrol       Date:  2018-06-26       Impact factor: 2.370

Review 3.  Impact of Inflammation on Ferritin, Hepcidin and the Management of Iron Deficiency Anemia in Chronic Kidney Disease.

Authors:  Norishi Ueda; Kazuya Takasawa
Journal:  Nutrients       Date:  2018-08-27       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.